A prognostic model for the prediction of survival in cystic fibrosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wood RE, Boat TF, Doershuk CF. Cystic fibrosis. Am Rev Respir Dis 1976;113:833–78.
British Paediatric Association Working Party on Cystic Fibrosis. Cystic fibrosis in the United Kingdom 1977–1985, an improving picture. BMJ 1988;297:1599–602.
MacLusky I, Levison H. Cystic fibrosis. In: Chernick V, ed. Disorders of the respiratory tract in children. Philadelphia: WB Saunders, 1990:692–729.
Madden BP, Hodson ME, Tsang V, Radley-Smith R, Khaghani A,Yacoub MY. Intermediate-term results of heartlung transplantation for cystic fibrosis. Lancet 1992;i: 1583–7.
Scott J, Higenbottam T, Hutter J, Hodson M, Stewart S, Penketh A, et al. Heart-lung transplantation for cystic fibrosis. Lancet 1988;ii:192–4.
Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187–91.
Bates DV, Macklem PT, Christie RV. Respiratory function in disease. Philadelphia: WB Saunders, 1971:93–4.
Society of Actuaries (Chicago). Build and blood pressure study. New York: Peter F Mallon Inc, 1959:16–23.
Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox’s multiple regression model for time-dependent variables. Scand J Gastroenterol 1986;21:163–74.
British Paediatric Association Working Party on Cystic Fibrosis. Cystic fibrosis in the United Kingdom 1968–88: incidence, population and survival. J Paediatr Peri Epidemiol 1993;7:157–66.
Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583–91.
Niellsen OH, Schiotz PO. Evaluation of centralised treatment 1945–1981. Acta Paediatr Scand 1982;Suppl 301: 107–19.
Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 1992;12:158–61.
Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327:1785–8.
Shepherd SL, Hovell MF, Slymen DJ, Harwood IR, Hofstetter CR, Granger LE, et al. Functional status as an overall measure of health in adults with cystic fibrosis: further validation of a generic health measure. J Clin Epidemiol 1992;45:117–25.
Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991;46:881–5.
Britton JR. Effects of social class, sex, and region of residence on age of death from cystic fibrosis. BMJ 1989;298:483–7.
Huang NN, Schidlow DV, Szatrowski TH, Palmer J, LarayaCuasay LR, Yeung W, et al. Clinical features, survival rate and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;82:871–9.
Hudson I, Phelan PD. Are sex, age at diagnosis, or mode of presentation prognostic factors in young adults with cystic fibrosis. Pediatr Pulmonol 1987;3:288–97.
Wagener JS, Taussig LM, Burrows B, Hernried L, Boat T. Comparison of lung function and survival patterns between cystic fibrosis and emphysema or chronic bronchitis patients. In: Strurgess JM, ed. Perspectives in cystic fibrosis: proceedings of the 8th International Cystic Fibrosis Congress, Mississauga, Ontario. Mississauga: Imperial Press, 1980: 236–45.
Sharples L, Hathaway T, Dennis C, Caine N, Higenbottam T, Wallwork J. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant 1993;12:669–74.
Levy LD, Durie PR, Pencharz PB, Corey ML. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr 1985;107:225–30.
Elborn JS, Cordon SM, Western PJ, MacDonald IA, Shale DJ. Tumour necrosis factor-, resting energy expenditure and cachexia in cystic fibrosis. Clin Sci 1993;85:563–8.
Tanner MS. Liver and biliary problems in cystic fibrosis. J R Soc Med 1992;85(Suppl 19):20–4.
Gaskin KJ, Waters DLM, Howman-Giles R, De Silva M, Earl JW, Martin HCO, et al. Liver disease and commonbile-duct stenosis in cystic fibrosis. N Engl J Med 1988; 318:340–6.
Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710–17.
Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histological features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1–7.
Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991;66:698–701.
Sokol RJ, Stall C. Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr 1990;52:203–8.
Webb LJ, Ross M, Markham RL, Webster ADW, Thomas HC, Sherlock S. Immune function in patients with extrahepatic portal venous obstruction and the effect of splenectomy. Gastroenterology 1980;79:99–103.
Bosch J, Arroyo V, Rodes J. Hepatic and systemic haemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. In: Epstein M, ed. The kidney in liver disease. New York: Elsevier Biomedical, 1983:423–40.